ASH 2019: Results of study comparing lenalidomide combined with rituximab with pi3k inhibitors for treatment of relapsed follicular lymphoma.
Home / Resource Library / Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis